News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Aman Chauhan: Congratulations to Crinetics Pharmaceuticals team on a very positive results for paltusotine phase 3 acromegaly study!
Photo taken from Aman Chauhan/Twitter
Sep 11, 2023, 18:28

Aman Chauhan: Congratulations to Crinetics Pharmaceuticals team on a very positive results for paltusotine phase 3 acromegaly study!

Quoting Aman Chauhan, Leader of the Sylvester Comprehensive Cancer Center’s Neuroendocrine Tumor Program, on Twitter: 

“Congratulations to Crinetics Pharmaceuticals team on a very positive results for paltusotine phase 3 acromegaly study!! We are now even more excited for Paltusotine Carcinoid study. Please checkout our Trials in Progress Poster from ENETS.”
For details click here.
Source: Aman Chauhan/Twitter
Aman Chauhan cancer Crinetics Pharmaceuticals OncoDaily Oncology paltusotine
Special Coverage
Insight
Sep 1, 2024, 13:58
Honouring and continuing the tradition of the Manneken Pis event
Insight
Sep 1, 2024, 12:34
Highlights from The ISEH 2024
Blog
Sep 1, 2024, 12:16
Peter Pisters: The end of an exceptional fiscal year at MD Anderson Cancer Center
Stories
Sep 1, 2024, 11:29
Running for a Cure: The Legacy of Terry Fox's Marathon of Hope
Insight
Sep 1, 2024, 10:46
Article of the day, September 1st, suggested by the Immune Oncology Research Institute
Insight
Sep 1, 2024, 10:41
Myeloma Paper of the Day, September 1st, suggested by Robert Orlowski
Insight
Sep 1, 2024, 09:56
Billy Rosa: Are Palliative Care specialists expected to provide extra support to primary team members
Insight
Sep 1, 2024, 09:53
Maximilian Mair: Translating the theranostic concept to neurooncology
Blog
Sep 1, 2024, 09:51
Sara Gutiérrez-Enríquez: Our Work on hereditary breast/ovarian cancer and Radiogenomics
Insight
Sep 1, 2024, 09:48
Phase III Keynote-789 Trial of Platinum + Pemetrexed +/- Pembrolizumab in EGFR + NSCLC
Blog
Sep 1, 2024, 09:23
Estela Rodriguez: The Inaugural class of Sylvester Comprehensive Cancer Center Emerging Leaders Program
Insight
Sep 1, 2024, 09:17
Geriatric assessment in oncology by Allison Magnuson et al.